scientific program • symposia - American Society for Reproductive ...

• Society for Assisted Reproductive Technology
• Reproductive Surgery (SRS)
• Endometriosis Special Interest Group
• Genetic Counseling Special Interest Group
• Menopause
• Pediatric and Adolescent Gynecology Special Interest
Group
• SMRU Traveling Scholars/MRU
• Reproductive Endocrinology and Infertility Fellows
• Outcome Predictors - Clinical: ART 2
• Procedures and Techniques - Clinical: ART
• Reproductive Biology: Animal and Experimental Models
• Sexuality Special Interest Group
• Reproductive Endocrinology and Infertility
__________________________________________________________
CONTRACEPTION
ROOM 224 E/F
Moderators: Rebecca H. Allen
Jeffrey Jensen
O-117 4:15 PM
EFFECTS OF THE PROSTAGLANDIN-SYNTHASE INHIBITOR
CELECOXIB ON OVULATION AND LUTEAL FUNCTION IN
WOMEN.
A. Edelman1,2 , J. Jensen1,2 , C. Doom1 , J. Hennebold2 . 1Obstetrics &
Gynecology, Oregon Health & Science University, Portland, OR;
2Reproductive Sciences, Oregon National Primate Research Center,
Beaverton, OR.
O-118 4:30 PM
EMERGENCY CONTRACEPTIVE PILLS AS A BACK UP
FOR LACTATIONAL AMENORRHEA METHOD (LAM) OF
CONTRACEPTION.
O. M. Shaaban 1 , S. A. Nour 2 , S. G. Hassen 2 , E. M. Yones 2 , M. A.
Kames 2 . 1 Department of Obstetrics and Gynecology, Faculty of
Medicine, Assiut University, Assiut, Egypt; 2 Department of Obstetrics
and Gynecological Nursing, Faculty of Nursing, Assiut University,
Assiut, Egypt.
O-119 4:45 PM
THE RISK OF VENOUS THROMBOEMBOLISM IN USERS OF AN
ETONOGESTREL/ETHINYLESTRADIOL CONTAINING VAGINAL
RING – INTERIM RESULTS FROM THE TASC STUDY.
J. Dinger, S. Moehner, T. Do Minh. ZEG - Berlin Center for
Epidemiology and Health Research, Berlin, Germany.
O-120 5:00 PM
INCUBATION OF cGMP-PRIMED MACAQUE OOCYTES WITH
A PHOSPHODIESTERASE 9 INHIBITOR PREVENTS NUCLEAR
MATURATION AND IN VITRO FERTILIZATION.
C. B. Hanna 1 , S. Yao 1 , J. T. Jensen 1,2 . 1 Reproductive Sciences, Oregon
National Primate Research Center, Beaverton, OR; 2 Department
of Obstetrics & Gynecology, Oregon Health & Science University
(OHSU), Portland, OR.
O-121 5:15 PM
AN RCT OF VARYING ORAL CONTRACEPTIVE REGIMENS IN THE
TREATMENT OF PRIMARY DYSMENORRHEA.
R. Dmitrovic 1 , R. S. Legro 2 , K. R. Allen 2 . 1 BetaPlus Center for
Reproductive Medicine, Zagreb, Croatia; 2 Penn State University
College of Medicine, Hershey, PA.
O-122 5:30 PM
EFFECTIVENESS AND TOLERABILITY OF A MONOPHASIC ORAL
CONTRACEPTIVE CONTAINING NOMEGESTROL ACETATE
(NOMAC) AND 17ß-ESTRADIOL (E2).
C. Westhoff 1 , A. M. Kaunitz 2 , W. Sommer 3 , L. Bahamondes 4 , P.
ORAL ABSTRACTS
Tuesday, October 18, 2011 4:15 pm –6:15 pm
Abstract Sessions
112
Darney 5 , C. Verhoeven 3 . 1 Columbia University, New York, NY;
2 University of Florida College of Medicine-Jacksonville, Jacksonville,
FL; 3 MSD, Netherlands; 4 University of Campinas, Campinas, SP, Brazil;
5 University of California, San Francisco, San Francisco, CA.
O-123 5:45 PM
COMBINED ORAL, TRANSDERMAL AND VAGINAL
CONTRACEPTIVES WORSEN INSULIN RESISTANCE AND
CHRONIC INFLAMMATION IN YOUNG HEALTHY NORMAL
WEIGHT WOMEN – A RANDOMIZED STUDY.
J. M. Puurunen 1,4 , T. T. Piltonen 1,2,4 , P. S. Hedberg 3 , A. O. Ruokonen 3 ,
L. C. Morin-Papunen 1 , J. S. Tapanainen 1,4 . 1 Department of
Obstetrics and Gynecology, Oulu University Hospital, Oulu, Finland;
2 Department of Obstetrics, Gynecology and Reproductive
Sciences, The University of California, San Francisco, San Francisco,
CA; 3 Department of Clinical Chemistry, Institute of Diagnostics,
University of Oulu, Oulu, Finland; 4 Department of Obstetrics and
Gynecology, Clinical Research Center, University of Oulu, Oulu,
Finland.
O-124 6:00 PM
CONTRACEPTION AFTER CANCER TREATMENT: DESCRIBING
METHODS, COUNSELING, AND UNINTENDED PREGNANCY RISK
AMONG WOMEN WHO ARE SURVIVORS OF REPRODUCTIVE
AGE CANCERS.
J. M. Letourneau, A. Craig, A. Katz, M. P. Rosen. Obstetrics,
Gynecology and Reproductive Sciences, University of California,
San Francisco, San Francisco, CA.
__________________________________________________________
NURSING
ROOM 231 A/C
Moderators: Shalini Gunawardena
Cynthia Wilson
O-125 4:15 PM
FERTILITY INTELLIGENCE: WHAT HOSPITAL EMPLOYEES DON’T
KNOW MAY SURPRISE YOU.
K. R. Hammond1 , N. A. Cataldo2 , J. W. Hicks1 , M. P. Steinkampf1 .
1 2 Alabama Fertility Specialists, Birmingham, AL; Birmingham, AL.
O-126 4:30 PM
PREDICTORS OF MULTIDIMENSIONAL STRESS IN PREGNANCIES
CONCEIVED VIA IN-VITRO FERTILIZATION.
E. L. Stevenson1 , C. M. Bergh2 . 1School of Nursing, Duke University,
Durham, NC; 2Reproductive Medicine Associates of New Jersey,
Morristown, NJ.
O-127 4:45 PM
DOES HUSBAND’S AGE AND SEMEN QUALITY IMPACTS THE
OUTCOMES OF IVF WITH DONATED OOCYTES?
P. Fettback1,2 , R. Miranda1 , J. R. Alegretti1 , M. Nichi1 , A. M. Rocha1 ,
E. L. A. Motta1,3 . 1Huntington Medicina Reprodutiva, São Paulo,
Brazil; 2Disciplina de Ginecologia, Faculdade de Medicina da
Universidade de São Paulo, São Paulo, Brazil; 3Departamento de
Ginecologia, Universidade Federal de São Paulo, São Paulo, Brazil.
O-128 5:00 PM
OOCYTE DONATION IVF: A NATIONAL SURVEY OF CURRENT
PRACTICE AND SIX-YEAR TRENDS.
K. R. Hammond1 , N. A. Cataldo2 , M. P. Steinkampf1 . 1Alabama Fertility Specialists, Birmingham, AL; 2Birmingham, AL.
O-129 5:15 PM
SAME-SEX FEMALE COUPLES AND FAMILY-BUILDING THROUGH
IVF: PATIENT AND TREATMENT DYNAMICS.
D. L. Cunningham, S. C. Pang, A. Moegle, J. C. Patel, K. J. Go. RSC
New England, Lexington, MA.